Terumo's $610m loss from losing a US plasma device customer signals material revenue risk.
Context
What happened: Terumo said it and U.S. customer CSL Plasma ended a supply agreement for a plasma device. CSL Plasma switched to devices from elsewhere for some locations.
Key numbers: Total loss of $610 million, including impairment losses. Terumo trimmed its full-year forecast.
Why it matters: The break with CSL Plasma led Terumo to cut its full-year forecast, reflecting the financial impact of losing the customer.